University of Florida
Gastroenterology fellowship · Gainesville, FL · University of Florida programs · Program website
Internal Medicine residency here · Other fellowships: Rheumatology · Cardiovascular Disease · Pulmonary and Critical Care · Hematology and Oncology · Nephrology · Infectious Disease · Endocrinology, Diabetes, and Metabolism · Geriatric Medicine
Roster not collected yet. There's no list of this program's own faculty, trainees, or papers yet. Below is University of Florida's research in gastroenterology, which the program shares with other departments and affiliated hospitals.
Gastroenterology at University of Floridashared by every program there, not this program's own
Institution-level: all gastroenterology publications from University of Florida and affiliated institutions, since 2022. Updated 2026-11-09; refreshed daily.
Works per year · * 2026 so far
Gastroenterology research topics at University of Florida
Papers in the window; each links to the list on OpenAlex.
- Liver Disease Diagnosis and Treatment 120
- Gallbladder and Bile Duct Disorders 52
- Inflammatory Bowel Disease 48
- Hepatocellular Carcinoma Treatment and Prognosis 42
- Liver Disease and Transplantation 41
- Gastroesophageal reflux and treatments 33
- Hepatitis C virus research 30
- Gastrointestinal motility and disorders 30
Most cited at University of Florida since 2024
All gastroenterology papers there on OpenAlex
- Modulation of metabolic, inflammatory and fibrotic pathways by semaglutide in metabolic dysfunction-associated steatohepatitisMaximilian Jara et al. · Nature Medicine · 2025 · PubMed · cited 111
- Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) in People With Diabetes: The Need for Screening and Early Intervention. A Consensus Report of the American Diabetes AssociationKenneth J. Cusi et al. · Diabetes Care · 2025 · PubMed · cited 417
- Addressing the High and Rising Global Burden of Metabolic Dysfunction‐Associated Steatotic Liver Disease ( MASLD ) and Metabolic Dysfunction‐Associated Steatohepatitis ( MASH ): From the Growing Prevalence to Payors' PerspectiveZobair M. Younossi et al. · Alimentary Pharmacology & Therapeutics · 2025 · PubMed · cited 68
- Pan-PPAR agonist lanifibranor improves insulin resistance and hepatic steatosis in patients with T2D and MASLDDiana Barb et al. · Journal of Hepatology · 2025 · PubMed · cited 101
- American Society for Gastrointestinal Endoscopy guideline on the diagnosis and management of GERD: summary and recommendationsMadhav Desai et al. · Gastrointestinal Endoscopy · 2024 · PubMed · cited 90
- Resmetirom therapy for metabolic dysfunction-associated steatotic liver disease: October 2024 updates to AASLD Practice GuidanceVincent Lingzhi Chen et al. · Hepatology · 2024 · PubMed · cited 235
- American Society for Gastrointestinal Endoscopy guideline on the role of therapeutic EUS in the management of biliary tract disorders: summary and recommendationsSwati Pawa et al. · Gastrointestinal Endoscopy · 2024 · PubMed · cited 93
- The Emerging Role of Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Metabolic Dysfunction-Associated SteatohepatitisLayla A. Abushamat et al. · Clinical Gastroenterology and Hepatology · 2024 · PubMed · cited 101
- Role of Insulin Resistance in the Development of Nonalcoholic Fatty Liver Disease in People With Type 2 Diabetes: From Bench to Patient CareJuan Patricio Nogueira et al. · Diabetes Spectrum · 2024 · PubMed · cited 131
- Pharmacological Approaches to Nonalcoholic Fatty Liver Disease: Current and Future TherapiesIdoia Genua et al. · Diabetes Spectrum · 2024 · PubMed · cited 74
Add to your program's websitea badge, your paper list, a feed
For program directors and coordinators. Both update with the site and need no account.
<a href="https://openprograms.org/programs/university-florida-college-medicine-gi"><img src="https://openprograms.org/programs/university-florida-college-medicine-gi/badge.svg" alt="University of Florida Gastroenterology fellowship on OpenPrograms" height="20"></a>Something wrong or missing on this page? Use the correction form below; changes show up in both.